Assenagon Asset Management’s ClearPoint Neuro CLPT Stock Holding History

Assenagon Asset Management’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-50,935	Closed	-$528K	–	1370
2022 Q3	$528K	Buy	+50,935	New	+$671K	﹤0.01%	1092
2022 Q2	–	Sell	-120,689	Closed	-$1.26M	–	1480
2022 Q1	$1.26M	Buy	120,689 +82,261	+214%	+$749K	﹤0.01%	996
2021 Q4	$431K	Buy	+38,428	New	+$575K	﹤0.01%	1223
2021 Q3	–	Sell	-48,255	Closed	-$921K	–	1304
2021 Q2	$921K	Buy	+48,255	New	+$932K	﹤0.01%	932

Other funds holding CLPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWM

Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Assenagon Asset Management's CLPT Position: Q4 2022 in Review

Assenagon Asset Management sold out of ClearPoint Neuro (CLPT) in Q4 2022, closing a stake of 50,935 shares — an estimated $528K sold.

Assenagon Asset Management first reported a position in CLPT in Q2 2021 and held it in 4 quarters. The position peaked at $1.26M in Q1 2022. 62 funds tracked by Wall St. Rank hold CLPT as of Q4 2022.

Assenagon Asset Management reported no remaining ClearPoint Neuro position as of Q4 2022 after selling out during the quarter.
Assenagon Asset Management sold 50,935 ClearPoint Neuro shares in Q4 2022, an estimated $528K.
Assenagon Asset Management first reported a position in ClearPoint Neuro in Q2 2021 and held it in 4 quarters.
Assenagon Asset Management's ClearPoint Neuro position peaked at $1.26M in Q1 2022.
62 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2022.

Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.